ABBVIE INC. - 1H - Technical analysis published on 04/25/2025 (GMT)
- 110
- 0
Click here for a new analysis!
- Timeframe : 1H
- - Analysis generated on
- Status : TARGET REACHED
Summary of the analysis
Additional analysis
Quotes
The ABBVIE INC. rating is 184.07 USD. The price has increased by +2.05% since the last closing and was traded between 179.99 USD and 188.70 USD over the period. The price is currently at +2.27% from its lowest and -2.45% from its highest.The Central Gaps scanner detects a bullish gap which is a sign that buyers have taken the lead in the very short term.
Opening Gap UP
Type : Bullish
Timeframe : Openning
A study of price movements over other periods shows the following variations:
Technical
Technical analysis of this 1H chart of ABBVIE INC. indicates that the overall trend is bullish. 71.43% of the signals given by moving averages are bullish. The overall trend is reinforced by the strong bullish signals from short-term moving averages. The Central Indicators market scanner currently does not detect any result that concerns moving averages.
Technical indicators are strongly bullish, suggesting that the price increase should continue.
Caution: the Central Indicators scanner currently detects an excess:
RSI indicator is overbought : over 70
Type : Neutral
Timeframe : 1 hour
CCI indicator is overbought : over 100
Type : Neutral
Timeframe : 1 hour
Pivot points : price is over resistance 1 (Daily)
Type : Neutral
Timeframe : 1 hour
Pivot points : price is over resistance 1 (Daily)
Type : Neutral
Timeframe : Weekly
Williams %R indicator is back under -50
Type : Bearish
Timeframe : 1 hour
Pivot points : price is over resistance 1 (Weekly)
Type : Neutral
Timeframe : 1 hour
Pivot points : price is over resistance 1 (Monthly)
Type : Neutral
Timeframe : 1 hour
Central Patterns, the market scanner focusing on chart patterns, resistances and supports found this result:
Near horizontal support
Type : Bullish
Timeframe : 1 hour
The Central Candlesticks scanner, specialised in Japanese candlesticks, did not identify any signals.
S3 | S2 | S1 | Price | R1 | R2 | R3 | |
---|---|---|---|---|---|---|---|
ProTrendLines | 167.73 | 172.78 | 179.67 | 184.07 | 187.85 | 194.69 | 200.12 |
Change (%) | -8.88% | -6.13% | -2.39% | - | +2.05% | +5.77% | +8.72% |
Change | -16.34 | -11.29 | -4.40 | - | +3.78 | +10.62 | +16.05 |
Level | Major | Minor | Intermediate | - | Intermediate | Intermediate | Major |
Pivot points can also be used to set your price objectives. Here is the price situation in relation to pivot points:
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 171.78 | 173.94 | 177.16 | 179.32 | 182.54 | 184.70 | 187.92 |
Camarilla | 178.89 | 179.38 | 179.88 | 180.37 | 180.86 | 181.36 | 181.85 |
Woodie | 172.30 | 174.21 | 177.68 | 179.59 | 183.06 | 184.97 | 188.44 |
Fibonacci | 173.94 | 176.00 | 177.27 | 179.32 | 181.38 | 182.65 | 184.70 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 157.58 | 163.66 | 168.33 | 174.41 | 179.08 | 185.16 | 189.83 |
Camarilla | 170.03 | 171.02 | 172.01 | 172.99 | 173.98 | 174.96 | 175.95 |
Woodie | 156.87 | 163.31 | 167.62 | 174.06 | 178.37 | 184.81 | 189.12 |
Fibonacci | 163.66 | 167.77 | 170.31 | 174.41 | 178.52 | 181.06 | 185.16 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 174.00 | 184.35 | 195.97 | 206.32 | 217.94 | 228.29 | 239.91 |
Camarilla | 201.56 | 203.57 | 205.59 | 207.60 | 209.61 | 211.63 | 213.64 |
Woodie | 174.65 | 184.67 | 196.62 | 206.64 | 218.59 | 228.61 | 240.56 |
Fibonacci | 184.35 | 192.74 | 197.92 | 206.32 | 214.71 | 219.89 | 228.29 |
Numerical data
The following are the details of the technical indicators and moving averages that were collected to generate this technical analysis:
RSI (14): | 71.70 | |
MACD (12,26,9): | 2.3500 | |
Directional Movement: | 31.72 | |
AROON (14): | 78.57 | |
DEMA (21): | 181.58 | |
Parabolic SAR (0,02-0,02-0,2): | 179.99 | |
Elder Ray (13): | 3.20 | |
Super Trend (3,10): | 177.13 | |
Zig ZAG (10): | 183.58 | |
VORTEX (21): | 1.2000 | |
Stochastique (14,3,5): | 58.88 | |
TEMA (21): | 183.20 | |
Williams %R (14): | -37.48 | |
Chande Momentum Oscillator (20): | 7.26 | |
Repulse (5,40,3): | -0.7500 | |
ROCnROLL: | 1 | |
TRIX (15,9): | 0.1500 | |
Courbe Coppock: | 7.14 |
MA7: | 175.66 | |
MA20: | 183.55 | |
MA50: | 196.42 | |
MA100: | 186.18 | |
MAexp7: | 181.58 | |
MAexp20: | 178.77 | |
MAexp50: | 176.91 | |
MAexp100: | 179.78 | |
Price / MA7: | +4.79% | |
Price / MA20: | +0.28% | |
Price / MA50: | -6.29% | |
Price / MA100: | -1.13% | |
Price / MAexp7: | +1.37% | |
Price / MAexp20: | +2.96% | |
Price / MAexp50: | +4.05% | |
Price / MAexp100: | +2.39% |
News
Don't forget to follow the news on ABBVIE INC.. At the time of publication of this analysis, the latest news was as follows:
- AbbVie Reports First-Quarter 2025 Financial Results
- AbbVie Submits Biologics License Application to U.S. FDA for TrenibotulinumtoxinE (TrenibotE) for the Treatment of Glabellar Lines
- AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults with Giant Cell Arteritis
- AbbVie to Host First-Quarter 2025 Earnings Conference Call
- AbbVie Showcases Early Pipeline and Scientific Advances in Oncology at AACR Annual Meeting 2025
Add a comment
Comments
0 comments on the analysis ABBVIE INC. - 1H